ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 106

Caregivers’ Perspectives on Barriers to Care in Juvenile Localized and Systemic Scleroderma

Leigh Stubbs1, Andrew Ferry2, Danielle Guffey1, Christina Loccke3, Erin Moriarty Wade3, Pamela Pour3, Kaveh Ardalan4, Peter Chiraseveenuprapund5, Ingrid Ganske6, Daniel Glaser7, Gloria Higgins8, Nadia Luca9, Katharine Moore10, Vidya Sivaraman11, Katie Stewart1, Natalia Vasquez Canizares12, Raegan Hunt1, Renata Maricevich1, Kathryn Torok13 and Suzanne Li14, 1Baylor College of Medicine, Houston, TX, 2Oregon Health and Science University, Portland, OR, 3n/a, 4Duke University School of Medicine, Durham, NC, 5University of California - San Diego, San Diego, CA, 6Boston Children’s Hospital and Harvard Medical School, Boston, MA, 7Yale University School of Medicine, New Haven, CT, 8Nationwide Childrens Hospital/ The Ohio State University, Columbus, OH, 9University of Calgary, Calgary, AB, Canada, 10University of Colorado / Children's Hospital Colorado, Denver, CO, 11Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 12Children's Hospital at Montefiore, New York, NY, 13University of Pittsburgh, Pittsburgh, PA, 14Hackensack Meridian School of Medicine, Joseph M. Sanzari Children's Hospital, Hackensack, NJ

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Access to care, Dermatology, Pediatric rheumatology, Scleroderma, Localized, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, March 31, 2023

Title: Posters: Clinical and Therapeutic II

Session Type: Poster Session B

Session Time: 5:00PM-6:00PM

Background/Purpose: Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare rheumatic diseases often associated with severe morbidities. Delays in diagnosis are common, putting children at risk for permanent damage and worse outcomes. This study investigated caregiver perspectives on barriers they encountered while seeking a diagnosis and care for their child’s scleroderma.

Methods: In this cross-sectional study, researchers recruited parents of juvenile LS or SSc patients from a virtual family scleroderma educational conference and a juvenile scleroderma online support group over three months to survey them about their child’s condition and factors affecting diagnosis and treatment.

Results: The response rate was 61% (73/120). The respondents comprised 38 parents of LS patients and 31 parents of SSc patients. Most patients were female (80%), and more than half were non-Hispanic white (55%). The majority of families had at least one person with a college education or higher (87%), traveled < 2 hours to see their doctor (83%), and had private insurance (75%). Nearly half had an annual household income > $100,000 (46%). Caregivers surveyed identified these main barriers to care: lack of knowledge about scleroderma in the medical community, finding reliable information about scleroderma in children, long wait times for a rheumatologist/specialist appointment, balance of school/work and child’s healthcare needs, medication side effects, and identifying effective medications. Respondents said the lack of knowledge about juvenile scleroderma was their most challenging barrier. Diagnosis and systemic treatment initiation were more than one year from initial presentation for approximately 28% and 36% of patients, respectively.

Conclusion: Caregivers of children with LS or SSc surveyed reported many common barriers to the diagnosis, treatment, and ongoing care of juvenile scleroderma. The biggest problem highlighted was the medical community’s lack of knowledge of scleroderma. However, most respondents had relatively high socioeconomic status, so additional studies are needed to reach a broader audience, including caregivers with limited English proficiency, geographical limitations, and financial constraints, to evaluate whether these problems are universal. Identifying care barriers will help direct efforts to address needs better, reduce disparities in care, and ultimately improve patient outcomes.


Disclosures: L. Stubbs: None; A. Ferry: None; D. Guffey: None; C. Loccke: None; E. Moriarty Wade: None; P. Pour: None; K. Ardalan: None; P. Chiraseveenuprapund: None; I. Ganske: None; D. Glaser: None; G. Higgins: None; N. Luca: None; K. Moore: None; V. Sivaraman: None; K. Stewart: None; N. Vasquez Canizares: None; R. Hunt: None; R. Maricevich: None; K. Torok: None; S. Li: Merck/MSD, 11.

To cite this abstract in AMA style:

Stubbs L, Ferry A, Guffey D, Loccke C, Moriarty Wade E, Pour P, Ardalan K, Chiraseveenuprapund P, Ganske I, Glaser D, Higgins G, Luca N, Moore K, Sivaraman V, Stewart K, Vasquez Canizares N, Hunt R, Maricevich R, Torok K, Li S. Caregivers’ Perspectives on Barriers to Care in Juvenile Localized and Systemic Scleroderma [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/caregivers-perspectives-on-barriers-to-care-in-juvenile-localized-and-systemic-scleroderma/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/caregivers-perspectives-on-barriers-to-care-in-juvenile-localized-and-systemic-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology